Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-16

Clinical Trial Update: Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery [NA]

View source ↗

Summary

A terminated clinical trial evaluating gemcitabine hydrochloride, docetaxel, and radiation therapy for uterine sarcoma that was surgically removed; results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DOCETAXEL (DOCETAXEL)
  • Gemcitabine hydrochloride (Gemcitabine hydrochloride)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Stage IA Uterine Sarcoma, Stage IB Uterine Sarcoma | NA | Status: TERMINATED | Results posted: 2023-08-16